新型自适应内耳量表验证:智能量化听力损失影响
本研究开发并验证了自适应版内耳量表,通过因子分析、项目反应理论评估内部一致性(n=2200),并在513例中检验聚合效度、区分效度、重测信度及反应度。结果显示自适应量表内部一致性高(Cronbach α 0.91),与听力图(Spearman ρ 0.30)及PROMIS等量表正相关,重测信度Cohen κ 0.6,得分增加10分对应正常听力几率增加10.4倍,且重测信度高于标准静态量表。
要点
- 自适应内耳量表内部一致性高(Cronbach α 0.91,95%CI >0.89)。
- 自适应量表得分与听力图结果正相关(Spearman ρ 0.30,95%CI 0.19-0.41)。
- 自适应得分增加10分与正常听力几率增加10.4倍相关。
核心结论
- 这种新型自适应验证工具具有临床适用性、内部一致性、可靠性、反应度,与听力图一致,且可靠性高于标准静态测试。
研究设计与样本
- 前瞻性验证研究,通过因子分析、项目反应理论评估和内部一致性评价开发自适应测试(n=2200)。
- 在513例中测量与标准静态测试和听力计测听的聚合效度与区分效度,并评估重测信度和反应度。
主要发现
- 因子分析显示条目反映单一领域(听力能力)。
- 内部一致性强(Cronbach α 0.91,95%CI >0.89)。
- 自适应量表得分与听力图结果正相关(Spearman ρ 0.30,95%CI 0.19-0.41),与PROMIS整体身体健康(Spearman ρ 0.29,95%CI 0.17-0.40)、社会健康评分和整体概览评分正相关。
- 重测信度Cohen κ 0.6(95%CI 0.5-0.7)。
- 自适应测试得分增加10分与正常听力几率增加10.4倍相关;自适应量表内部一致性、效度和反应度与标准静态量表相当,重测信度更高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To develop and validate a novel adaptive version of the Inner EAR scale, which efficiently quantifies the patient-centered impact of hearing loss. Adaptive testing is a vetted, established means to provide targeted questions that assess each individual to achieve increased accuracy with less work for respondents. METHODS: A prospective validation study was performed. The adaptive test was developed through factor analysis, item response theory assessments, and evaluation of internal consistency (n = 2200). Convergent and discriminant validity were measured in relation to standard static testing and measured audiometry (n = 513). Assessments of intra-rater reliability and responsiveness to change were also performed. RESULTS: Factor analysis demonstrated that items reflected one domain (hearing ability). Internal consistency was strong (Cronbach alpha 0.91, 95% CI: > 0.89). Convergent validity was also demonstrated, with positive associations between adaptive scale scores and audiogram results (Spearman rho 0.30, 95% CI: 0.19-0.41), overall PROMIS physical health (Spearman rho 0.29, 95% CI: 0.17-0.40), social health scores, and global overview scores. Intra-rater reliability was also demonstrated (Cohen kappa 0.6, 95% CI: 0.5-0.7). Responsiveness to change and discriminant validity (an increase in adaptive test score of 10 was associated with 10.4-fold increase in odds of normal hearing) were also observed. The adaptive scale had comparable internal consistency, validity, and responsiveness to change, and higher intra-rater reliability than the standard static scale. CONCLUSIONS: This novel adaptive validated instrument is clinically applicable, internally consistent, reliable, responsive, aligns with audiometry, and has higher reliability than standard static testing. LEVEL OF EVIDENCE: 2 (diagnostic or monitoring test).
引用
- Kim M, Corrales CE, Prince AA, et al. Validation of a Novel Adaptive Inner EAR Scale to Intelligently Quantify the Impact of Hearing Loss. Laryngoscope. 2025. PMID: 40026241. doi:10.1002/lary.32087
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。